Selhub Jacob, Rosenberg Irwin H
Tufts University, Jean Mayer USDA, Human Nutrition Center on Aging, Boston, MA, United States.
Biochimie. 2016 Jul;126:71-8. doi: 10.1016/j.biochi.2016.04.010. Epub 2016 Apr 27.
The recent increase in the intake of folic acid by the general public through fortified foods and supplements, has raised safety concern based on early reports of adverse health outcome in elderly with low B12 status who took high doses of folic acid. These safety concerns are contrary to the 2015 WHO statement that "high folic acid intake has not reliably been shown to be associated with negative healeffects". In the folic acid post-fortification era, we have shown that in elderly participants in NHANES 1999-2002, high plasma folate level is associated with exacerbation of both clinical (anemia and cognitive impairment) and biochemical (high MMA and high Hcy plasma levels) signs of vitamin B12 deficiency. Adverse clinical outcomes in association with high folate intake were also seen among elderly with low plasma B12 levels from the Framingham Original Cohort and in a study from Australia which combined three elderly cohorts. Relation between high folate and adverse biochemical outcomes were also seen in the Sacramento Area Latino Study on Aging (High Hcy, high MMA and lower TC2) and at an outpatient clinic at Yale University where high folate is associated with higher MMA in the elderly but not in the young. Potential detrimental effects of high folic acid intake may not be limited to the elderly nor to those with B12 deficiency. A study from India linked maternal high RBC folate to increased insulin resistance in offspring. Our study suggested that excessive folic acid intake is associated with lower natural killer cells activity in elderly women. In a recent study we found that the risk for unilateral retinoblastoma in offspring is 4 fold higher in women that are homozygotes for the 19 bp deletion in the DHFR gene and took folic acid supplement during pregnancy. In the elderly this polymorphism is associated with lower memory and executive scores, both being significantly worse in those with high plasma folate. These and other data strongly imply that excessive intake of folic acid is not always safe in certain populations of different age and ethnical/genetic background.
近期,普通民众通过强化食品和补充剂摄入的叶酸有所增加,鉴于早期有报告称,维生素B12水平较低的老年人服用高剂量叶酸后出现了不良健康后果,这引发了人们对叶酸安全性的担忧。这些安全担忧与世界卫生组织2015年的声明相悖,该声明称“尚未确凿证明高叶酸摄入量与负面健康影响有关”。在叶酸强化补充时代之后,我们发现,在1999 - 2002年美国国家健康与营养检查调查(NHANES)的老年参与者中,高血浆叶酸水平与维生素B12缺乏的临床症状(贫血和认知障碍)和生化指标(高甲基丙二酸血症和高同型半胱氨酸血症)的加重有关。在弗雷明汉姆原始队列中血浆B12水平较低的老年人以及澳大利亚一项合并了三个老年队列的研究中,也观察到了与高叶酸摄入量相关的不良临床结果。在萨克拉门托地区拉丁裔老龄化研究(高同型半胱氨酸血症、高甲基丙二酸血症和较低的钴胺素转运蛋白2)以及耶鲁大学的一家门诊诊所也发现了高叶酸与不良生化指标之间的关联,在该诊所中,高叶酸与老年人较高的甲基丙二酸血症有关,但与年轻人无关。高叶酸摄入量的潜在有害影响可能不仅限于老年人,也不仅限于维生素B12缺乏者。印度的一项研究将母亲红细胞叶酸水平高与后代胰岛素抵抗增加联系起来。我们的研究表明,过量摄入叶酸与老年女性自然杀伤细胞活性降低有关。在最近的一项研究中,我们发现,携带二氢叶酸还原酶(DHFR)基因19bp缺失纯合子且在孕期服用叶酸补充剂的女性,其后代患单侧视网膜母细胞瘤的风险高出4倍。在老年人中,这种基因多态性与较低的记忆力和执行能力评分有关,血浆叶酸水平高的人群的这些评分明显更差。这些数据以及其他数据强烈表明,在不同年龄、种族/遗传背景的特定人群中,过量摄入叶酸并非总是安全的。